Identification of TNFAIP3 as relapse biomarker and potential therapeutic target for MOG antibody associated diseases

MOG-antibody associated disease (MOG-AAD) is a recently recognized demyelinating disorder predominantly affecting children but also occurs in adults, with a relapsing course in approximately 50% of patients. We evaluated peripheral blood mononuclear cells from MOG-AAD patients by flow cytometry and...

Descripción completa

Detalles Bibliográficos
Autores principales: Saxena, Shrishti, Lokhande, Hrishikesh, Gombolay, Grace, Raheja, Radhika, Rooney, Timothy, Chitnis, Tanuja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381621/
https://www.ncbi.nlm.nih.gov/pubmed/32709905
http://dx.doi.org/10.1038/s41598-020-69182-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381621/
https://www.ncbi.nlm.nih.gov/pubmed/32709905
http://dx.doi.org/10.1038/s41598-020-69182-w

Ejemplares similares